Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hearing aid tech aims to cut noise, boost clarity

NCT ID NCT07224919

Symptom relief Sponsor: Jonathan Vaisberg Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Aug 11, 2026 · Updated 3 times

Summary

This study tested a hearing aid feature called AutoFocus360, which automatically points microphones toward whoever is speaking. Thirty adults with mild to moderate hearing loss listened to audio clips and compared AutoFocus360 to standard settings. The goal was to see if it made speech clearer and background noise less bothersome.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
AutoFocus 360 hearing aid feature
What this could lead to
If successful, this could support claims that AutoFocus360 helps people with hearing loss understand speech better in noisy environments.
What could go wrong
This is a small, completed study with only 30 participants, so results may not apply to everyone. It tested short audio clips, not real-world use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Nov 2025

Finished

Mar 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 99 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults (18-99 years) * Binaural, symmetric, sensorineural N2 (mild) to N5 (moderate-severe) hearing loss * Fluent in English Exclusion Criteria: * Minors (\< 18 years * Normal hearing or hearing loss \> N6 (severe)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hearing loss are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hearing loss disorder sensorineural hearing loss disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hearing loss

Contacts and locations

Locations

  • Sonova Canada Inc.

    Kitchener, Ontario, N2E 1Y6, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.